The Latest Breaking News from Medicare

It is an expense that everyone will have, but few people have considered how they will cover it during retirement. This six-figure expense could bankrupt you.

Use the Mulligan Rule to undo these seven costly retirement errors. While you can’t go back in time, some retirement choices allow for a “correction shot.”

A federal judge in Rhode Island ordered the Trump administration to deliver SNAP payments in full to all of the states by Friday, November 7....

The Social Security Administration has officially announced the 2026 cost-of-living adjustment (COLA), and while it’s technically a raise, many seniors say it won’t make a...

When most people think of Medicare, they picture hospital stays, doctor visits, and prescription drugs. But what often goes unnoticed is how much mental health...

Trump launches "TrumpRx" program to cut prices of Wegovy and Zepbound, making weight-loss drugs more affordable for Americans.

Nearly 10,000 people in America turn 65 every day. Why is that significant? It signals Medicare eligibility and shines a light on Medicare supplement insurance, known as Medigap.

Certain GLP-1 weight loss medications will be available for as little as $149 per month, a sharp drop from the current average retail price of $1,000–$1,350.

President Donald Trump unveiled a major pricing and coverage deal with drug giants Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) on Thursday, pledging to make blockbuster weight-loss drugs like Zepbound and Wegovy significantly cheaper and accessible for millions of Americans.

Down almost 50% from all-time highs, UnitedHealth stock trades at a compelling valuation while offering investors an attractive dividend yield.

President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.